PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsVincristine sulfate
Vincristine sulfate
Vincristine (vincristine sulfate) is a small molecule pharmaceutical. Vincristine sulfate was first approved as Oncovin on 1982-01-01. It is used to treat hodgkin disease, leukemia, neuroblastoma, non-hodgkin lymphoma, and rhabdomyosarcoma amongst others in the USA. The pharmaceutical is active against tubulin beta chain.
Download report
Favorite
Drugs Approved for Childhood Cancers
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
urogenital diseasesD000091642
hemic and lymphatic diseasesD006425
hereditary congenital and neonatal diseases and abnormalitiesD009358
immune system diseasesD007154
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
vincristine sulfateANDA2024-04-24
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
L: Antineoplastic and immunomodulating agents
L01: Antineoplastic agents
L01C: Plant alkaloids and other natural products, antineoplastic drugs
L01CA: Vinca alkaloids and analogues, antineoplastic
L01CA02: Vincristine
HCPCS
Code
Description
J9370
Vincristine sulfate, 1 mg
J9371
Injection, vincristine sulfate liposome, 1 mg
Clinical
Clinical Trials
1345 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.9112
Non-hodgkin lymphomaD008228C85.911
Mantle-cell lymphomaD020522C83.111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Plasmablastic lymphomaD000069293C83.38712
Large-cell lymphoma immunoblasticD0164008712
Aids-related lymphomaD016483EFO_10013654812
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340379
Hematologic neoplasmsD0193375228
Blast crisisD001752167
Lymphoproliferative disordersD008232Orphanet_2442D47.9167
Reactive arthritisD016918EFO_0007460M02.366
Adult t-cell leukemia-lymphomaD015459C91.5335
VomitingD014839R11.1134
Show 73 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PinealomaD010871213
Myelodysplastic-myeloproliferative diseasesD05443722
HypersensitivityD006967EFO_0003785T78.4011
Deltaretrovirus infectionsD006800EFO_100130311
Htlv-i infectionsD015490EFO_000731611
Composite lymphomaD05861711
Hematologic diseasesD006402EFO_0005803D75.911
MycosesD009181B35-B4911
Sezary syndromeD012751C84.111
Mycosis fungoidesD009182C84.011
Show 1 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NauseaD009325R11.033
ConstipationD003248K59.022
Cognitive dysfunctionD060825G31.8411
Non-small-cell lung carcinomaD00228911
AtaxiaD001259R27.011
Ataxia telangiectasiaD001260Orphanet_100G11.311
TelangiectasisD01368411
Cerebellar ataxiaD00252411
OtotoxicityD00008101511
Nerve degenerationD00941011
Show 14 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameVincristine sulfate
INNvincristine
Description
Vincristine is a vinca alkaloid with formula C46H56N4O10 found in the Madagascar periwinkle, Catharanthus roseus. It is used (commonly as the corresponding sulfate salt)as a chemotherapy drug for the treatment of leukaemia, lymphoma, myeloma, breast cancer and head and neck cancer. It has a role as a tubulin modulator, a microtubule-destabilising agent, a plant metabolite, an antineoplastic agent and a drug. It is a methyl ester, an acetate ester, a tertiary alcohol, a member of formamides, an organic heteropentacyclic compound, an organic heterotetracyclic compound, a tertiary amino compound and a vinca alkaloid. It is a conjugate base of a vincristine(2+). It derives from a hydride of a vincaleukoblastine.
Classification
Small molecule
Drug classvinca alkaloids
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
Identifiers
PDB
CAS-ID2068-78-2
RxCUI
ChEMBL IDCHEMBL501867
ChEBI ID79401
PubChem CID5978
DrugBankDBSALT000314
UNII ID5J49Q6B70F (ChemIDplus, GSRS)
Target
Agency Approved
TUBB
TUBB
Organism
Homo sapiens
Gene name
TUBB
Gene synonyms
TUBB5
NCBI Gene ID
Protein name
tubulin beta chain
Protein synonyms
beta Ib tubulin, epididymis secretory sperm binding protein, tubulin beta-1 chain, Tubulin beta-5 chain, tubulin, beta polypeptide
Uniprot ID
Mouse ortholog
Tubb5 (22154)
tubulin beta-5 chain (Q3UF52)
Alternate
No data
Variants
No data
Financial
Revenue by drug
$
£
Marqibo Spectrum Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 5,094 documents
View more details
Safety
Black-box Warning
Black-box warning for: Vincristine sulfate
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
91,418 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use